Quantum Si Investor & Analyst Day Highlights Proteome Detection Roadmap

jueves, 20 de noviembre de 2025, 8:13 am ET1 min de lectura
QSI--

Quantum Si held an investor day on November 19, 2025, featuring updates and presentations on the Proteus program, long-term technology roadmap, amino acid detection, post-translational modification analysis, and the path to Proteus launch. The company's CEO, Jeff Hawkins, highlighted the complexity of the proteome and the potential applications of its technology across various end markets, including academic research, pharmaceuticals, and clinical diagnostics.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios